Lake Forest, CA – September 19 2025 – Sutra Medical Inc. is proud to announce that Dr. Sanjeevan Pasupati will present the First-in-Human (FIH) case of the Sutra Hemi-Valve at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2025 Conference.
The case will be featured in:
✨ Innovation Session 17: New Generation Transcatheter Mitral Technologies: Case-in-a-Box Demonstrations ✨
This milestone procedure highlights the potential of the Sutra Hemi-Valve to provide new treatment options for patients with mitral regurgitation who are unsuitable for surgery or transcatheter edge-to-edge repair (TEER).
TCT 2025 will take place October 25–28, 2025, at the Moscone Center in San Francisco, California.
Sutra Medical’s CEO, Dr. Wei Sun, will also attend the meeting, joining colleagues, innovators, and partners from around the world to advance therapies in structural heart disease.